BSX

#163
Boston Scientific Corp.
64.04 USD
+1.63%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
64.03
64.16
Intervallo Annuale
60.59
109.49
Variazione giornaliera
+1.63%
Variazione Mensile
-7.43%
Variazione di 6 mesi
-33.21%
Variazione Annuale
-32.43%
Chiusura Precedente
63.01
Apertura
64.13
Bid
Ask
Minimo
64.03
High
64.16
Volume
1 442
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 95.03 B
  • Employee 59 K
  • Founded 1979
  • CEO Michael F. Mahoney
  • Website www.bostonscientific.com
  • Headquarter Delaware, United States
  • FIGI BBG000C0LW92
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
49.15
Rapporto prezzo/fatturato
7.1

Boston Scientific Corporation

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

Notizie